By reformulating existing ICS and LABA with its proprietary excipient technology, Aquilon Pharma makes ICS-LABA combinations soluble in water. This allows AQ002S to be optimized for any type of Nebulisers.

The answer to today’s needs in the field of asthma medication

Inhaled fixed ICS-LABA combinations are the basic treatment option for asthma patients

ICS-LABA can be delivered via several types of devices, however it is not commonly delivered via nebulization.

Vibrating mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Unfortunately, there is no ICS-LABA in solution available yet for these devices. Aquilon Pharma’s AQ002S liquid formulation (solution) for nebulization is the key.

L’article AQ002S est apparu en premier sur Aquilon Pharma.

By reformulating existing ICS with its proprietary excipient, Aquilon Pharma makes ICS soluble in water.

The answer to today’s needs in the field of asthma medication

Inhaled corticosteroids (ICS) are the basic treatment option to suppress airway inflammation.

ICS can be delivered via several types of devices, however it is not commonly delivered via soft mist nebulization.Vibrating mesh nebulizers have become the first choice for new nebulized pharmaceutical drugs. Unfortunately, there is no ICS in solution available yet for these devices. Aquilon Pharma’s AQ001S liquid formulation (solution) for nebulization is the key.

L’article AQ001S est apparu en premier sur Aquilon Pharma.